Discuss Mitochondria Based Therapeutics: A New Class of Novel Therapies for Age-Related Diseases

Time: 12:15 pm
day: Day Two

Details:

  • Examine how mitochondrial dysfunction underlies many chronic and age-related diseases
  • Discover how mitochondrial derived peptides regulate multiple body systems
  • Evaluate mitochondria based therapeutics targeting NASH, fibrosis, ARDS, oncology

Speakers:

Steven Engle
Steven Engle

Mr. Engle joined CohBar as Chief Executive Officer and Director in 2019. From 2011 to 2019, he served as the Chief Executive Officer of Averigon, an advisory firm to the life science industry. From 2007 to 2011, Mr. Engle was Chairman, Chief Executive Officer and President of XOMA Corporation (NASDAQ: XOMA), a publicly traded biotechnology…Read more